Ad
related to: sublingual allergen immunotherapy meaning
Search results
Results from the WOW.Com Content Network
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. [1] [2] Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.
Allergen immunotherapy is an alternative treatment considered in some patients, with a success rate of 80%-90% in reducing symptoms, [3] but requiring a much longer duration of therapy. The choice of medications depends on the disease to be treated, its severity and patient factors.
Desensitization approaches for food allergies are generally at the research stage. They include: [2] oral immunotherapy, which involves building up tolerance by eating a small amount of (usually baked) food; sublingual immunotherapy, which involves placing a small drop of milk or egg white under the tongue;
Allergy immunotherapy can be administered orally (as sublingual tablets or sublingual drops), or by injections under the skin (subcutaneous). [46] [47] Immunotherapy contains a small amount of the substance that triggers the allergic reactions. [48] Ladders are also used for egg and milk allergies as a home-based therapy mainly for children.
Allergen immunotherapy is the only treatment that alters the disease mechanism. [27] Immunotherapy can be administered orally (as sublingual tablets [28] or sublingual drops), or by injections under the skin (subcutaneous). [29] Subcutaneous immunotherapy is the most common form and has the largest body of evidence supporting its effectiveness ...
This page was last edited on 23 May 2020, at 19:04 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply ...
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
Since 2003, Stallergenes has been involved in a clinical development programme whose objective is to develop proprietary medicines intended to cover the main allergens responsible for more than 80% of respiratory allergies. [citation needed] [19] Oralair is the first sublingual immunotherapy tablet resulting from this programme.
Ad
related to: sublingual allergen immunotherapy meaning